Blood Testing

Blood Testing Market Outlook

The global blood testing market is projected to reach approximately USD 89 billion by 2035, with a robust compound annual growth rate (CAGR) of around 7.5% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing prevalence of chronic diseases such as diabetes and cancer, alongside a rising demand for advanced diagnostic procedures. Furthermore, technological advancements in blood testing, including the development of point-of-care testing devices, are anticipated to significantly enhance the market. The growing awareness of preventive healthcare and the importance of regular health check-ups are also contributing factors to this upward trend. As the global population ages, the need for effective blood diagnostics will likely escalate, propelling the market forward.

Growth Factor of the Market

The blood testing market is experiencing substantial growth due to several key factors. Firstly, the rising incidence of infectious diseases worldwide necessitates frequent and accurate blood tests for diagnosis and monitoring. Secondly, the ongoing advancements in laboratory technologies, such as automation and artificial intelligence, are enhancing the efficiency and accuracy of blood tests. Thirdly, the increasing health-consciousness among the population is driving individuals to seek regular health check-ups, thereby boosting the demand for blood testing services. Moreover, government initiatives aimed at improving healthcare infrastructure and access to diagnostic services are fostering market growth. Lastly, the shift towards personalized medicine is leading to the development of specialized blood tests that cater to individual health needs, further propelling market expansion.

Key Highlights of the Market

• The market is expected to grow significantly due to the rising prevalence of chronic diseases.
• Technological advancements are enhancing the accuracy and speed of blood testing.
• Increasing health awareness is driving demand for regular blood testing.
• Government initiatives to improve healthcare access bolster market growth.
• The trend towards personalized medicine is leading to innovative blood testing solutions.

By Product Type

Complete Blood Count:

Complete Blood Count (CBC) tests are fundamental diagnostic tools that provide comprehensive information about the cellular components of blood. CBC tests measure various parameters, including red blood cell count, white blood cell count, hemoglobin levels, and platelet count. These tests are crucial for diagnosing conditions such as anemia, infections, and blood disorders. The increasing prevalence of these conditions contributes to the growth of the CBC segment. Furthermore, advancements in technology have led to more sophisticated automated analyzers that provide quick and accurate results, further propelling the demand for CBC tests.

Blood Chemistry Tests:

Blood chemistry tests analyze specific substances in the blood, such as electrolytes, enzymes, and hormones, providing essential information about organ function and metabolic processes. These tests are invaluable for diagnosing and monitoring a range of diseases, including liver disease, kidney disease, and diabetes. The rising incidence of these health conditions, coupled with advancements in testing methodologies that enable quicker turnaround times, is driving growth in the blood chemistry tests segment. Additionally, the increasing awareness of the importance of regular health screening is promoting the utilization of these tests in preventive healthcare settings.

Blood Culture Tests:

Blood culture tests are critical for identifying infections in the bloodstream, including bacteremia and fungemia. These tests help in determining the presence of pathogens, guiding appropriate treatment regimens. The increasing prevalence of sepsis and other bloodstream infections is a significant growth driver for this segment. Furthermore, advancements in microbial detection technologies and the development of automated systems for blood culture testing have improved the speed and reliability of results. As healthcare providers increasingly prioritize early detection and intervention for infections, the demand for blood culture tests is expected to rise.

Blood Typing:

Blood typing tests are essential for determining an individual's blood group, which is critical for safe blood transfusions and organ transplants. The demand for blood typing is primarily driven by the need for transfusion services in surgeries, trauma cases, and chronic disease management. Technological advancements in blood typing methods, such as molecular typing and automated systems, are enhancing the accuracy and efficiency of these tests. Additionally, the increasing number of surgical procedures and the growing awareness of the importance of blood donation are contributing to the expansion of the blood typing segment.

Coagulation Tests:

Coagulation tests are pivotal in assessing the blood's ability to clot, which is vital for diagnosing bleeding disorders and monitoring anticoagulant therapy. Conditions such as hemophilia and deep vein thrombosis necessitate regular coagulation testing. The rise in these disorders, along with an aging population that is more prone to clotting issues, is driving demand in this segment. Furthermore, advancements in point-of-care testing devices are facilitating quick and easy coagulation assessments, contributing to the segment's growth. The increasing focus on personalized medicine also emphasizes the need for tailored anticoagulant therapy, further enhancing the importance of coagulation tests.

By Application

Infectious Diseases:

The application of blood testing in infectious diseases is critical for the timely diagnosis and management of various infections, including viral, bacterial, and parasitic diseases. The rising incidence of infectious diseases globally, particularly in the wake of pandemics, underscores the importance of effective blood diagnostics. Blood tests, such as serological tests and PCR assays, are commonly employed to detect pathogens and monitor immune responses. The growing awareness of infectious diseases and the need for prompt treatment are driving the demand for blood testing services in this application category.

Diabetes:

Diabetes is a chronic condition that requires regular monitoring of blood glucose levels to manage the disease effectively. Blood tests such as fasting blood glucose, HbA1c, and continuous glucose monitoring play a crucial role in diabetes management. The increasing prevalence of diabetes worldwide, along with lifestyle changes and an aging population, is significantly fueling the growth of blood testing applications in this area. Additionally, advancements in home glucose monitoring devices are making blood testing more accessible and convenient for patients, further promoting the market growth.

Cancer:

Blood testing plays a vital role in cancer diagnosis, treatment monitoring, and prognosis. Tests like tumor marker assays help detect specific proteins associated with certain types of cancer, providing valuable insights into disease progression. The rising incidence of cancer cases globally is a significant factor driving growth in this application segment. Moreover, advancements in liquid biopsy technology are enabling non-invasive cancer detection through blood tests, further revolutionizing cancer diagnostics. As the focus on early detection and personalized treatment approaches intensifies, the demand for blood testing services in oncology is expected to grow substantially.

Cardiovascular Diseases:

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality globally, necessitating regular screening and monitoring. Blood tests are critical for assessing cholesterol levels, inflammatory markers, and other indicators related to heart health. The increasing prevalence of risk factors such as obesity, hypertension, and sedentary lifestyles is driving demand in this application category. Furthermore, advancements in biomarker discovery and the development of blood tests for early detection of heart disease are enhancing the market's growth potential. As healthcare initiatives increasingly focus on preventive care, blood testing for cardiovascular diseases will likely see substantial expansion.

Autoimmune Diseases:

Blood testing is essential for diagnosing and monitoring autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. Tests such as antinuclear antibody (ANA) tests and rheumatoid factor (RF) assays are commonly utilized in this context. The rising prevalence of autoimmune disorders, coupled with an improved understanding of their complexities, is fueling growth in this application segment. Additionally, advancements in laboratory technologies that enable the analysis of multiple autoantibodies simultaneously are enhancing diagnostic accuracy. As awareness and research into autoimmune diseases continue to grow, the demand for blood testing services in this area is expected to rise.

By Distribution Channel

Hospitals:

Hospitals are a primary distribution channel for blood testing services, offering a wide range of diagnostic tests to inpatients and outpatients. The comprehensive facilities available in hospitals, along with access to advanced laboratory technologies, make them a preferred choice for blood testing. The increasing patient volume, driven by the rise in chronic diseases and surgical procedures, is propelling the demand for blood tests in hospital settings. Furthermore, hospitals often have the resources to conduct specialized tests, contributing to their dominance in the blood testing market.

Clinics:

Clinics, including private practice and specialized health facilities, serve as important distribution channels for blood testing services. They provide convenient access to essential diagnostic tests, often with shorter waiting times compared to hospitals. The growing trend of outpatient care and preventive health check-ups is boosting the demand for blood testing in clinics. Additionally, the increasing number of clinics, especially in urban areas, is providing patients with more options for blood testing services. The ability of clinics to offer personalized care and patient-centric services further enhances their attractiveness as a distribution channel.

Diagnostic Laboratories:

Diagnostic laboratories play a pivotal role in the blood testing market, specializing in a wide array of tests and analyses. These facilities are equipped with advanced technologies and skilled professionals, ensuring high-quality testing services. The growing reliance on diagnostic laboratories for accurate and timely results is driving their demand in the market. Moreover, as healthcare systems focus on improving efficiency and reducing costs, many hospitals and clinics are outsourcing blood testing services to specialized laboratories. This trend is expected to fuel growth in the diagnostic laboratory segment of the blood testing market.

Blood Banks:

Blood banks are crucial for ensuring the availability of safe blood products for transfusion. They conduct various blood tests to screen for infectious diseases and determine blood type, which is essential for maintaining the safety of blood supplies. The increasing demand for blood transfusions in surgical procedures and trauma care is driving growth in this distribution channel. Furthermore, initiatives to encourage blood donation and the establishment of new blood donation centers are enhancing the operational capacity of blood banks. As the demand for safe and reliable blood products continues to rise, blood banks will play an increasingly important role in the blood testing market.

Home Care Settings:

Home care settings are emerging as an important distribution channel for blood testing, driven by the growing trend of personalized healthcare and patient convenience. The availability of portable blood testing devices allows patients to conduct tests in the comfort of their homes, thereby enhancing accessibility and compliance. The increasing prevalence of chronic diseases, which require regular monitoring, is propelling the demand for home blood testing solutions. Additionally, the ongoing advancements in telemedicine and remote patient monitoring are facilitating the integration of blood testing services into home care, further bolstering this segment's growth.

By Testing Type

Routine Blood Tests:

Routine blood tests encompass a variety of standard diagnostic tests that are commonly performed to assess overall health and detect potential medical conditions. These tests include CBC, blood chemistry panels, and metabolic panels, which provide crucial insights into a patient’s health status. The growing emphasis on preventive medicine and routine health check-ups is driving demand for routine blood tests globally. Furthermore, the increasing awareness of the importance of early diagnosis and monitoring of chronic conditions is contributing to the growth of this segment.

Specialty Blood Tests:

Specialty blood tests are designed to diagnose specific diseases or conditions and often require specialized equipment or procedures. These tests include hormone level assessments, tumor marker tests, and genetic testing. The rising prevalence of chronic illnesses and the growing interest in personalized medicine are key drivers of the specialty blood tests segment. Additionally, advancements in laboratory techniques, such as next-generation sequencing and liquid biopsies, are expanding the scope and accuracy of specialty blood testing. As healthcare providers increasingly focus on tailored treatment plans, the demand for specialty blood tests is expected to rise.

Rare Blood Tests:

Rare blood tests are essential for diagnosing uncommon diseases that may not be detected through routine testing. These tests often require specialized expertise and technology. The increasing recognition of rare diseases and the need for accurate diagnostics are driving growth in this segment. Additionally, advancements in genetic testing and biomarker discovery are enabling the development of more targeted rare blood tests. As the focus on rare diseases continues to gain momentum in the medical community, the demand for these specialized blood tests is likely to increase significantly.

Point-of-Care Testing:

Point-of-care testing (POCT) refers to diagnostic tests performed at or near the site of patient care, providing immediate results that can guide clinical decisions. This testing method is becoming increasingly popular due to its speed and convenience, particularly in emergency settings and home care. The growing demand for rapid and efficient diagnostics, especially in situations where timely decision-making is crucial, is propelling the POCT segment. Moreover, advancements in portable testing devices and technologies are enhancing the accuracy and reliability of point-of-care blood tests, further driving growth in this area.

Genetic Testing:

Genetic testing involves analyzing DNA to identify genetic disorders and assess an individual's risk of developing certain diseases. This segment is gaining traction due to the increased awareness of hereditary conditions and the growing emphasis on personalized medicine. The advancements in sequencing technologies and bioinformatics are making genetic testing more accessible and affordable. As healthcare providers and patients seek more precise and tailored treatment options based on genetic profiles, the demand for genetic testing services is expected to rise significantly. This evolution in healthcare is driving innovation and expansion within the blood testing market.

By Region

The North American region dominates the blood testing market, accounting for approximately 40% of the global market share. The high prevalence of chronic diseases, coupled with advanced healthcare infrastructure and a strong emphasis on research and development, contributes to this regional leadership. Additionally, the growing adoption of advanced diagnostic technologies and the presence of key market players in the region further bolster its market position. The CAGR for the North American blood testing market is projected to be around 6.8% during the forecast period, reflecting the ongoing demand for innovative testing solutions and preventive healthcare services.

In Europe, the blood testing market is anticipated to grow steadily, accounting for roughly 30% of the global share. The region is witnessing an increasing focus on early diagnosis and patient-centric healthcare, driving the demand for blood testing services. The CAGR in Europe is expected to be around 6.5%, propelled by the rising awareness of the importance of routine health screenings and advancements in diagnostic technologies. The Asia Pacific region is also emerging as a significant market, driven by the growing population, increasing prevalence of chronic diseases, and rising healthcare expenditure. Collectively, these regions are shaping the future landscape of the global blood testing market.

Opportunities

One significant opportunity in the blood testing market lies in the ongoing advancements in diagnostic technologies. As innovation continues to reshape the landscape, emerging technologies such as microfluidics, lab-on-a-chip platforms, and artificial intelligence in diagnostics present new avenues for growth. These technologies not only enhance the accuracy and speed of blood tests but also enable the development of novel testing methods that cater to specific health conditions. Additionally, as healthcare systems increasingly prioritize preventive care and early diagnosis, there is a growing market for innovative blood testing solutions that align with these trends. Companies that invest in research and development to harness these technological advancements will be well-positioned to capture a larger market share.

Another promising opportunity is the rising demand for home-based healthcare solutions. With the growing trend towards personalized medicine and self-monitoring, patients are increasingly seeking convenient options for blood testing at home. This shift presents a unique opportunity for companies to develop portable testing devices and user-friendly applications that empower patients to monitor their health effectively. Furthermore, the integration of telemedicine and remote patient monitoring can enhance patient engagement and streamline the healthcare process. By focusing on the development of home testing solutions and establishing strong distribution networks, companies can tap into this burgeoning market and address the evolving needs of patients.

Threats

Despite the promising growth prospects, the blood testing market faces several threats that could hinder its progress. One significant threat is the increasing regulatory scrutiny and compliance requirements associated with diagnostic testing. Stricter regulations may lead to delays in product approvals, increased costs, and challenges in maintaining compliance with quality standards. Additionally, the rapid pace of technological advancements can result in market volatility, as companies must continuously innovate to stay competitive. The presence of alternative diagnostic methods and home testing solutions may also pose a threat to traditional blood testing services, potentially affecting market dynamics and revenue generation for established players.

Another critical threat to the blood testing market is the potential for data security breaches and cyber threats. As healthcare systems become increasingly digitized, the risk of unauthorized access to sensitive patient information grows. Any data breaches can lead to significant financial losses, reputational damage, and a loss of consumer trust. Companies in the blood testing market must prioritize robust cybersecurity measures to safeguard patient data and comply with data protection regulations. Failure to address these threats can result in legal repercussions and may deter patients from utilizing blood testing services.

Competitor Outlook

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Medtronic
• Quest Diagnostics
• Laboratory Corporation of America (LabCorp)
• Eurofins Scientific
• Bio-Rad Laboratories
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Hologic, Inc.
• PerkinElmer, Inc.
• Grifols S.A.

The competitive landscape of the blood testing market is characterized by the presence of several established players and emerging companies vying for market share. Major companies like Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers dominate various segments of the market, leveraging their extensive product portfolios, advanced technologies, and strong distribution networks. These organizations are continuously investing in research and development to introduce innovative blood testing solutions and improve existing products. Additionally, partnerships, collaborations, and acquisitions are common strategies employed by these companies to strengthen their market positions and expand their reach in the global market.

Companies such as Quest Diagnostics and Laboratory Corporation of America (LabCorp) are key players in the diagnostic laboratory segment, offering a wide range of blood testing services. Their focus on enhancing operational efficiencies and incorporating advanced diagnostic technologies has positioned them as leaders in the market. Furthermore, the rise of point-of-care testing has opened new opportunities for companies like Thermo Fisher Scientific and BD, which are developing portable testing devices to meet the growing demand for rapid and convenient testing solutions. As competition intensifies, these companies must remain agile and responsive to changing market dynamics to maintain their competitive edge.

Emerging companies in the blood testing market are also making their mark by focusing on niche segments and innovative testing solutions. For instance, firms specializing in genetic testing and personalized medicine are gaining traction, driven by the increasing awareness of the importance of tailored healthcare. These companies often adopt agile business models and leverage cutting-edge technologies to differentiate themselves from established players. As the blood testing market continues to evolve, collaboration between traditional diagnostic companies and startups may become increasingly common, fostering innovation and expanding the range of available testing solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Grifols S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Quest Diagnostics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Sysmex Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Eurofins Scientific
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Bio-Rad Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Siemens Healthineers
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ortho Clinical Diagnostics
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Laboratory Corporation of America (LabCorp)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Testing Market, By Application
    • 6.1.1 Infectious Diseases
    • 6.1.2 Diabetes
    • 6.1.3 Cancer
    • 6.1.4 Cardiovascular Diseases
    • 6.1.5 Autoimmune Diseases
  • 6.2 Blood Testing Market, By Product Type
    • 6.2.1 Complete Blood Count
    • 6.2.2 Blood Chemistry Tests
    • 6.2.3 Blood Culture Tests
    • 6.2.4 Blood Typing
    • 6.2.5 Coagulation Tests
  • 6.3 Blood Testing Market, By Testing Type
    • 6.3.1 Routine Blood Tests
    • 6.3.2 Specialty Blood Tests
    • 6.3.3 Rare Blood Tests
    • 6.3.4 Point-of-Care Testing
    • 6.3.5 Genetic Testing
  • 6.4 Blood Testing Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Diagnostic Laboratories
    • 6.4.4 Blood Banks
    • 6.4.5 Home Care Settings

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Blood Testing Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Testing market is categorized based on

By Product Type

• Complete Blood Count
• Blood Chemistry Tests
• Blood Culture Tests
• Blood Typing
• Coagulation Tests

By Application

• Infectious Diseases
• Diabetes
• Cancer
• Cardiovascular Diseases
• Autoimmune Diseases

By Distribution Channel

• Hospitals
• Clinics
• Diagnostic Laboratories
• Blood Banks
• Home Care Settings

By Testing Type

• Routine Blood Tests
• Specialty Blood Tests
• Rare Blood Tests
• Point-of-Care Testing
• Genetic Testing

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Medtronic
• Quest Diagnostics
• Laboratory Corporation of America (LabCorp)
• Eurofins Scientific
• Bio-Rad Laboratories
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Hologic, Inc.
• PerkinElmer, Inc.
• Grifols S.A.